GEMAYEL GEORGES 4
4 · SUPERNUS PHARMACEUTICALS, INC. · Filed Feb 21, 2025
Insider Transaction Report
Form 4
GEMAYEL GEORGES
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2025-02-19+7,296→ 7,296 totalExercise: $33.52Exp: 2035-02-19→ Common Stock (7,296 underlying) - Award
Restricted Stock Unit
2025-02-19+4,475→ 4,475 total→ Common Stock (4,475 underlying)
Holdings
- 13,315
Common Stock
Footnotes (3)
- [F1]The option vests on February 19, 2026.
- [F2]Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting.
- [F3]These restricted stock units will be settled in common stock upon vesting, which will occur on February 19, 2026.